Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Jeffrey L Bebensee, MD
Family Practice · DES MOINES, IA · NPI 1174509228
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 776 | 215 |
| Losartan Potassium | Losartan Potassium | 320 | 84 |
| Levothyroxine Sodium | Levothyroxine Sodium | 304 | 74 |
| Metformin Hcl | Metformin Hcl | 300 | 75 |
| Lisinopril | Lisinopril | 286 | 82 |
| Amlodipine Besylate | Amlodipine Besylate | 266 | 76 |
| Omeprazole | Omeprazole | 235 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 228 | 59 |
| Simvastatin | Simvastatin | 225 | 60 |
| Gabapentin | Gabapentin | 165 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 156 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 152 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 151 | 34 |
| Glimepiride | Glimepiride | 148 | 46 |
| Furosemide | Furosemide | 145 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 138 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 124 | 38 |
| Tramadol Hcl | Tramadol Hcl | 113 | 43 |
| Allopurinol | Allopurinol | 112 | 33 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 110 | 27 |
| Ozempic | Semaglutide | 108 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 104 | 27 |
| Alprazolam | Alprazolam | 100 | 21 |
| Meloxicam | Meloxicam | 96 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 88 | 30 |
| Potassium Chloride | Potassium Chloride | 88 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 79 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 78 | 19 |
| Sertraline Hcl | Sertraline Hcl | 77 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 72 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 71 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 68 | 25 |
| Atenolol | Atenolol | 66 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 66 | 17 |
| Famotidine | Famotidine | 65 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 64 | 14 |
| Bupropion Xl | Bupropion Hcl | 63 | 22 |
| Alendronate Sodium | Alendronate Sodium | 61 | 18 |
| Eliquis | Apixaban | 61 | 15 |
| Warfarin Sodium | Warfarin Sodium | 59 | 13 |
| Memantine Hcl | Memantine Hcl | 58 | 14 |
| Trazodone Hcl | Trazodone Hcl | 58 | 21 |
| Lorazepam | Lorazepam | 55 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 19 |
| Prednisone | Prednisone | 52 | 41 |
| Carvedilol | Carvedilol | 51 | 11 |
| Baclofen | Baclofen | 49 | suppressed |
| Chlorthalidone | Chlorthalidone | 49 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 13 |
| Finasteride | Finasteride | 45 | 11 |
| Xarelto | Rivaroxaban | 44 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 43 | 14 |
| Sumatriptan Succinate | Sumatriptan Succinate | 43 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 41 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 41 | 12 |
| Cephalexin | Cephalexin | 40 | 30 |
| Ezetimibe | Ezetimibe | 39 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | 25 |
| Donepezil Hcl | Donepezil Hcl | 37 | 13 |
| Clonazepam | Clonazepam | 36 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | 12 |
| Ketoconazole | Ketoconazole | 36 | 25 |
| Celecoxib | Celecoxib | 35 | 11 |
| Spironolactone | Spironolactone | 35 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 33 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 33 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 31 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 31 | 18 |
| Ibuprofen | Ibuprofen | 29 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Cefdinir | Cefdinir | 28 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Pregabalin | Pregabalin | 28 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 24 | suppressed |
| Naproxen | Naproxen | 24 | 14 |
| Arnuity Ellipta | Fluticasone Furoate | 23 | suppressed |
| Temazepam | Temazepam | 23 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 16 |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 18 |
| Bumetanide | Bumetanide | 18 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 18 | suppressed |
| Nabumetone | Nabumetone | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 17 |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Jardiance | Empagliflozin | 16 | suppressed |
| Sod Sulf-Potass Sulf-Mag Sulf | Sodium, Potassium,mag Sulfates | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Dulera | Mometasone/Formoterol | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Mesalamine | Mesalamine | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Relistor | Methylnaltrexone Bromide | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Eletriptan Hbr | Eletriptan Hydrobromide | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error